Depression News and Research

Latest Depression News and Research

Global study on working memory and influence of advertising on behaviour launched

Is your glass half full or half empty? Are you eternally optimistic or permanently pessimistic? What could this mean for your mental health? The British Science Association today launches a global study testing your working memory in relation to your mental health and then investigating the influence of advertising on your behaviour.

20 Jul 2010

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Here are highlights from the July issue of Mayo Clinic Women's HealthSource. You may cite this publication as often as you wish. Mayo Clinic Women's HealthSource attribution is required.

20 Jul 2010

Eisai's NDA for BANZEL Oral Suspension accepted for FDA review

Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's NDA for BANZEL® (rufinamide) Oral Suspension (40 mg/mL).

19 Jul 2010

AHRQ: 12M people with mental health, substance abuse problems visited emergency department in 2007

Nearly 12 million visits made to U.S. hospital emergency departments in 2007 involved people with a mental disorder, substance abuse problem, or both, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. This accounts for one in eight of the 95 million visits to emergency departments by adults that year.

17 Jul 2010

Research Roundups: Health IT progress; Telecare and cancer pain; State exchanges; Adults with no medical care

eHealth/Commonwealth Fund: National Progress Report On eHealth - This extensive report examines changes in the adoption and use of health information technology (HIT) since 2007, as assessed by a group of more than 100 experts.

17 Jul 2010

Impact of circadian dysregulation on mental, physical health

Circadian (daily) rhythms are found in all functions - e.g. performance, mood, endocrine rhythms, behaviour, sleep timing. The biological clocks that control circadian rhythms are based on a genetic programme of interacting molecules in cells throughout the body, coordinated by a ´master clock´ in the brain and synchronised by external cues, mainly light.

16 Jul 2010

New studies explore how child soldiers adjust after they return to their homes

Despite international bans, more than 250,000 children fight as soldiers in 86 countries across the globe, almost half of them in Africa. Two new studies explored how these children adjust after they return to their homes. Key to successful adaptation, the studies found, was the characteristics of the communities to which the children returned.

16 Jul 2010

Healthcare professionals need to develop greater understanding of specific needs of lesbian patients

Healthcare professionals need to develop greater understanding of the specific needs of lesbian patients and adopt a more sensitive approach to the advice they give them, according to research in the July issue of the Journal of Clinical Nursing

16 Jul 2010

Study finds unhappy families unhappy in two distinct ways

Contrary to Leo Tolstoy's famous observation that "happy families are all alike; every unhappy family is unhappy in its own way," a new psychology study confirms that unhappy families, in fact, are unhappy in two distinct ways. And these dual patterns of unhealthy family relationships lead to a host of specific difficulties for children during their early school years.

16 Jul 2010

All dementia isn't Alzheimer's disease: Mayo Clinic

Occasional misplaced keys or forgotten names don't mark the beginning of dementia. All dementia isn't Alzheimer's disease. Some dementia symptoms can be reversed. Those facts and many more are covered in Deciphering Dementia, a supplemental Special Report to the July issue of Mayo Clinic Women's HealthSource

16 Jul 2010

Brain imaging studies can provide biomarkers for depression diagnosis: Study

Depression, known to be a condition with impaired psychosocial functioning that severely impacts the quality of life of patients and families, is actually defined with specific clinical symptoms such as sadness, difficulty to experience pleasure, sleep problems etc., present for at least two weeks. At least 40% of depressed patients actually benefit from an antidepressant treatment, whereas 20-30% of patients may suffer from chronic depression that negatively impacts their quality of life. In order to improve the efficiency of treatment and reduce the burden of depressive disorders, depression needs to be defined at the neurobiological level.

16 Jul 2010

Citizens Bank, HealthPlus of Michigan engage employees in workplace wellness program

Two mid-size companies headquartered in Flint—Citizens Bank and HealthPlus of Michigan—recently put their heads together to creatively engage employees in a workplace wellness program.

16 Jul 2010

Current global economic crisis finds few bright spots in mental health spending: Study

As the current global economic crisis drives up the demand for mental health care services, cash-strapped agencies are slashing mental health budgets, according to a new Brandeis University study out this month in the International Journal of Mental Health. However, while most nations are cutting spending, a handful of countries are earmarking funding to meet the anticipated growth in mental health problems.

16 Jul 2010

Researchers study recovery patterns of children affected by Hurricane Katrina

Rebuilding schools after Hurricane Katrina and providing supportive environments and relationships have helped many children reduce their levels of overall trauma from the hurricane that devastated the Gulf Coast in August 2005, according to a new study. A second study found that girls had distinct stress reactions from boys in the aftermath of the storm.

16 Jul 2010

The Children's Hospital, UCH to jointly establish new center for advanced maternal fetal medicine

The Children's Hospital and the University of Colorado Hospital have finalized an agreement to jointly establish a center for advanced maternal fetal medicine offering state-of-the-art care for high-risk pregnant women and their babies. The two leading academic medical centers have individually provided such services for more than three decades, and by building on already existing adult and pediatric expertise, they together will be able to provide unparalleled care and treatment for the region's most at-risk moms and babies.

16 Jul 2010

Columbia scientists discover new way to alleviate chronic pain

Columbia scientists working to combat injury-related depression, substance abuse and suicide due to unremitting, persistent pain may have discovered a new way of treating that pain: a powerful analgesic dubbed N60 that leads to neither tolerance nor addiction.

16 Jul 2010

MPI reduces depressive symptoms: Study

This randomized controlled trial aimed to evaluate the effectiveness of a nurse-led minimal psychological intervention (MPI) in chronically ill elderly persons with minor depression or mild-to-moderate major depression, and type II diabetes or chronic obstructive pulmonary disease. Nine months after the intervention, patients receiving the MPI showed a 50% reduction in depressive symptoms relative to baseline values and diabetic MPI patients had a better quality of life than diabetic controls.

16 Jul 2010

Noscira presents results of Nypta Phase IIa clinical trial for AD at ICAD 2010

Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.

16 Jul 2010

Glaxo announces a $2.3 billion in legal liability charges

British pharmaceutical giant GlaxoSmithKline, announced this Thursday that its second-quarter charges related to legal cases involving the two drugs Avandia (diabetes drug) and Paxil (drug for anxiety and depression) would run up to $2.36 billion. Avandia’s use and its potential risk of causing heart problems were being debated this week by an advisory panel to the US Food & Drugs Administration (FDA).

16 Jul 2010

First Edition: July 15, 2010

Headlines topping today's news include reports about the White House release of new coverage rules for certain screening tests and other types of preventive care, and calls from the GOP for hearings on Berwick's recess appointment to run Medicare and Medicaid top today's news.

15 Jul 2010

Depression News and Research

Latest Depression News and Research

Global study on working memory and influence of advertising on behaviour launched

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Eisai's NDA for BANZEL Oral Suspension accepted for FDA review

AHRQ: 12M people with mental health, substance abuse problems visited emergency department in 2007

Research Roundups: Health IT progress; Telecare and cancer pain; State exchanges; Adults with no medical care

Impact of circadian dysregulation on mental, physical health

New studies explore how child soldiers adjust after they return to their homes

Healthcare professionals need to develop greater understanding of specific needs of lesbian patients

Study finds unhappy families unhappy in two distinct ways

All dementia isn't Alzheimer's disease: Mayo Clinic

Brain imaging studies can provide biomarkers for depression diagnosis: Study

Citizens Bank, HealthPlus of Michigan engage employees in workplace wellness program

Current global economic crisis finds few bright spots in mental health spending: Study

Researchers study recovery patterns of children affected by Hurricane Katrina

The Children's Hospital, UCH to jointly establish new center for advanced maternal fetal medicine

Columbia scientists discover new way to alleviate chronic pain

MPI reduces depressive symptoms: Study

Noscira presents results of Nypta Phase IIa clinical trial for AD at ICAD 2010

Glaxo announces a $2.3 billion in legal liability charges

First Edition: July 15, 2010

Innovation in neuroscience drug discovery - eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Depression News and Research

Latest Depression News and Research

Innovation in neuroscience drug discovery - eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in